Concurrent Chemoradiotherapy With or Without Metronomic Capecitabine in High-Risk T1-2N1M0 NPC
Clinical trial NCT07248670 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07248670
- Sponsor
- Chongqing University Cancer Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-04
- Primary completion
- 2031-12-31
- Enrollment
- 252
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.